First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans

The availability of direct oral anticoagulants has caused a paradigm shift in the management of thrombosis. Rivaroxaban and apixaban are 2 direct oral anticoagulants whose target specificity is activated factor X (FXa). However, it is still not fully understood if and how xabans impact platelet func...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Appl Thromb Hemost
Autores principales: Nehaj, Frantisek, Sokol, Juraj, Ivankova, Jela, Mokan, Michal, Kovar, Frantisek, Stasko, Jan, Mokan, Marian
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2017
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714725/
https://ncbi.nlm.nih.gov/pubmed/29050502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029617734310
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares